未登录

T

Tian Fang

Jilin University

H指数:6

被引数:216

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diffuse Large B-Cell Lymphoma Patients with Bone Involvement Treated with Polatuzumab Vedotin-Based Therapy Exhibit Poorer Progression-Free Survival: A Real-World Retrospective Study in Chinese Patients

弥漫性大B细胞淋巴瘤伴骨侵犯患者接受Polatuzumab Vedotin为基础的治疗后无进展生存期较差：一项中国患者的真实世界回顾性研究

IF23.1

2024-11-050

PRE

Efficacy and Tolerability of Dose-Adjusted Brentuximab Vedotin in Lymphoma: A Chinese Single-Center Retrospective Chart Review Study

剂量调整的 Brentuximab Vedotin 在淋巴瘤中的有效性与耐受性：一项中国单中心回顾性病历审查研究

IF23.1

2024-11-050

PRE

Causal associations between thyroid dysfunction and COVID-19 susceptibility and severity: A bidirectional Mendelian randomization study

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-09-0617

OAAI

An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-232

OAAI

Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by reducing expression of androgen receptor and 5α-reductase in a rat model

JOURNAL OF INTEGRATIVE MEDICINE-JIM

IF4

2021-05-018

PREAI

A PCR-Based Technique to Track the Geographic Origin of Plasmodium falciparum With 23-SNP Barcode Analysis

FRONTIERS IN PUBLIC HEALTH

IF3.4

2021-04-163

OAAI

Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase

SCIENTIFIC REPORTS

IF3.9

2019-12-2323

OAAI